Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2012

01-03-2012 | Case report

Hydromorphone overdose

Fatal respiratory arrest: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
…
Literature
1.
Paparella S.Intravenous HYDROmorphone: can you manage the risk?. [Review]. Journal of Emergency Nursing 37: 377-80 quiz 424, No. 4, Jul 2011 - USA
Metadata
Title
Hydromorphone overdose
Fatal respiratory arrest: case report
Publication date
01-03-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213920-00088

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Paroxetine

Case report

Carbamazepine

Case report

Azathioprine/infliximab

Case report

Tetracosactide

Case report

Chorionic gonadotropin/follitropin-α

Case report

Iopamidol